Sidney Kimmel Comprehensive Cancer at Johns Hopkins

Baltimore, Maryland 27287

3 studies enrolling now · 8 studies all time

What they study most

Advanced Colorectal Cancer, Advanced Esophageal Adenocarcinoma, Advanced Gastric Cancer, Advanced Gastroesophageal Junction Cancer, Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor, Advanced or Metastatic MTAP-deleted Solid Tumors, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastroesophageal Junction Adenocarcinoma, High-risk Myelodysplastic Syndrome (MDS)

Studies at this site

• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors — Recruiting now
• A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors — Recruiting now
• Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors — Recruiting now
• A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies — Stopped early
• A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification — Stopped early
• An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors — Stopped early
• A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome — Completed
• Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome — Completed